Literature DB >> 10681352

Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.

A Rosenau1, B Cattier, N Gousset, P Harriau, A Philippon, R Quentin.   

Abstract

A plasmid-encoded extended-spectrum TEM beta-lactamase with a pI of 5.5 was detected in a Capnocytophaga ochracea clinical isolate. The bla gene was associated with a strong TEM-2 promoter and was derived from bla(TEM-1a) with a single-amino-acid substitution: Glu(104)-->Lys, previously assigned to TEM-17, which is thus the first TEM beta-lactamase to be reported in the phylum Flavobacter-Bacteroides.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10681352      PMCID： PMC89760          DOI： 10.1128/AAC.44.3.760-762.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Bacterial evolution.

Authors:  C R Woese
Journal:  Microbiol Rev       Date:  1987-06

2.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S T Chen; R C Clowes
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

4.  In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.

Authors:  J L Rummens; B Gordts; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

5.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Isolation of a strain of beta-lactamase-producing Capnocytophaga ochracea.

Authors:  G Arlet; M J Sanson-Le Pors; S Castaigne; Y Perol
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Antimicrobial susceptibility of Capnocytophaga.

Authors:  S W Forlenza; M G Newman; A L Horikoshi; U Blachman
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

9.  In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.

Authors:  G Arlet; M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

10.  Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia.

Authors:  B Kristensen; H C Schønheyder; N A Peterslund; S Rosthøj; N Clausen; W Frederiksen
Journal:  Scand J Infect Dis       Date:  1995
View more
  11 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Nathalie Burggraeve; Michel Cormier; Martine Bonnaure-Mallet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Conserved Mechanism of Conformational Stability and Dynamics in G-Protein-Coupled Receptors.

Authors:  Supriyo Bhattacharya; Romelia Salomon-Ferrer; Sangbae Lee; Nagarajan Vaidehi
Journal:  J Chem Theory Comput       Date:  2016-10-17       Impact factor: 6.006

4.  Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.

Authors:  Trude Handal; Chantal Giraud-Morin; Dominique A Caugant; Isabelle Madinier; Ingar Olsen; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Adaptive Processes Change as Multiple Functions Evolve.

Authors:  Portia M Mira; Bjørn Østman; Candace Guzman-Cole; Suzanne Sindi; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 6.  Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment.

Authors:  Mark E Rupp; Paul D Fey
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Complete genome sequence of Capnocytophaga ochracea type strain (VPI 2845).

Authors:  Konstantinos Mavrommatis; Sabine Gronow; Elizabeth Saunders; Miriam Land; Alla Lapidus; Alex Copeland; Tijana Glavina Del Rio; Matt Nolan; Susan Lucas; Feng Chen; Hope Tice; Jan-Fang Cheng; David Bruce; Lynne Goodwin; Sam Pitluck; Amrita Pati; Natalia Ivanova; Amy Chen; Krishna Palaniappan; Patrick Chain; Loren Hauser; Yun-Juan Chang; Cynthia D Jeffries; Thomas Brettin; John C Detter; Cliff Han; James Bristow; Markus Göker; Manfred Rohde; Jonathan A Eisen; Victor Markowitz; Nikos C Kyrpides; Hans-Peter Klenk; Philip Hugenholtz
Journal:  Stand Genomic Sci       Date:  2009-09-24

8.  Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.

Authors:  Anne Jolivet-Gougeon; Zohreh Tamanai-Shacoori; Laurent Desbordes; Virginie Gandemer; Jean-Louis Sixou; Nolwenn Morvan-Graveline; Michel Cormier; Martine Bonnaure-Mallet
Journal:  BMC Infect Dis       Date:  2005-05-09       Impact factor: 3.090

9.  Whole genome sequencing of extended-spectrum β-lactamase producing Klebsiella pneumoniae isolated from a patient in Lebanon.

Authors:  Sima Tokajian; Jonathan A Eisen; Guillaume Jospin; Anna Farra; David A Coil
Journal:  Front Cell Infect Microbiol       Date:  2015-04-08       Impact factor: 5.293

Review 10.  The use of platensimycin and platencin to fight antibiotic resistance.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Emrah Sefik Abamor; Sezen Canim Ates; Rabia Cakir Koc; Meral Miraloglu; Serhat Elcicek; Serkan Yaman; Gokce Unal
Journal:  Infect Drug Resist       Date:  2013-09-18       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.